• Contact
  • +31 (0)30 800 4800
  • nl | en
  • Home
  • About BBio
    • Our story
    • How it started
    • Science park
    • Together with
  • What we produce
    • Product overview
    • How we do it
    • Report side effects
  • Look inside
    • Projects
    • News
  • Contact
+31 (0)30 800 4800
nl | en



From cell to vaccine.
Quality first.

 

From cell to Vaccine.
This is how we do it.

Developing a vaccine takes a lot of effort. To be able to supply the world’s population with reliable vaccines, our product undergoes quite a journey. We will gladly show you how we do this!

How we do it.

BCG
Bilthoven Biologicals produces BCG for the treatment of bladder cancer on behalf of third parties. 
Combination DT-IPV vaccine
The DT-IPV combination vaccine (diphteria, tetanus and poliomyelitis) can be used as the first (primary) inoculation, or as a booster vaccination.
Poliomyelitis vaccine (IPV)
This vaccine is also used in the worldwide polio eradication program.
Tetanus vaccine
The Tetanus vaccine protects against infections with the Tetanus bacterium.
Alle vaccins

facts & figures
Number of doses IPV BBio 2014-2020

156.092.196 doses IPV
were delivered between 2014 en 2020
129 countries
over the world use IPV from BBio
On 6 different continents
BBio contributes to the eradication of polio
On 25th of August 2020 WHO declared Africa polio free
the certification came four years after the last case of polio in Africa was detected.
1992-1993 polio last occurred
in the Netherlands

The story of our vaccines

News

Actually, it’s a very beautiful story

Bilthoven Biologicals is renowned worldwide for its polio vaccine,. CEO Jan-Eric Zandbergen tells us how this came about. An article by Julie Houben for the Biltsche Courant.
News

Adar Poonawalla in the NRC Handelsblad

In July 2020 Adar Poonawalla was interviewed for the NRC Handelsblad
News

Oxford Awards Honorary Degree to Dr. Cyrus Poonawalla

Dr. Cyrus Poonawalla, Founder and Chairman of the Serum Institute of India, was among the eight distinguished men and women who were awarded an honorary degree by Oxford University at Encaenia.
Meer verhalen
  • About BBio
  • Look inside
  • Contact
Our vaccines
  • BCG
  • Tetanus vaccine
  • Combination DT-IPV vaccine
  • Poliomyelitis vaccine (IPV)
  • Report side effects
Latest vacancies
  • Technical Engineer
  • Operator II
  • Supervisor Viral Bulk Productie
  • Scientist Formulation Process
Contact
Visiting address
Antonie van Leeuwenhoeklaan 13
3721 MA Bilthoven

+31 (0)30 800 4800
info@bbio.nl
Travel directions
© 2021 Bilthoven Biologicals | Algemene voorwaarden | Privacyverklaring
Thank you for visiting our website! We use cookies to ensure that our website works better for the visitor. We also use cookies for our web statistics. More uitleg.No problemRather not